Cyclin D1 Kainate Pentylenetetrazole CA1 Excitotoxicity Seizure Hippocampus Cell cycle Apoptosis Excitatory neurons G1-phase cyclin D1 (cD1) expression has been documented in post-mitotic neurons undergoing apoptosis, leading others to propose that attempted cell cycle re-entry may induce cell death. Here, cD1 immunoreactivity was found in a subpopulation of healthy excitatory neurons throughout the brain. Most striking was the selective cD1 expression in hippocampal pyramidal neurons, an especially vulnerable cell group. Seizure threshold, cD1 induction and CA1 neuron death were examined following application of kainate (KA) or pentylenetetrazole (PTZ) in cD1 heterozygous (+/−) and wildtype mice to determine whether baseline cD1 correlates with pathology. cD1+/− mice displayed resistance to KA, but not PTZ-induced seizures and had reduced or equivalent cytotoxicity respectively, compared with wildtype. KA administration, but not PTZ, induced cD1 expression. These findings suggest that basal cD1 expression may render hippocampal circuits more susceptible to particular epileptogenic agents and excitotoxic cell death, though cD1 is not a direct precipitant in apoptosis.
Introduction
are positive regulators of the mid-G1-transition -the only point in the cycle when a cell can commit to another round of division or exit the cell cycle (Sherr and Roberts, 2004) . The cyclins D activate binding partners cyclin-dependent kinases 4 or 6 that catalyze the initial inactivating phosphorylation of the retinoblastoma protein (pRb) and resultant de-repression of proliferation-associated E2F target genes and also, sequester cdk inhibiting proteins, p57and p27, from the cyclin E/cdk2 holoenzyme complex, which completely inactivates pRb and allows for cell-cycle progression. Disruption of tightly regulated G1/S phase cyclin expression results in cell-cycle arrest. Non-redundant functions of D-type cyclin subtypes are demonstrated by distinct impairments observed in mice deficient in one D-type (Sicinski et al., 1995 (Sicinski et al., , 1996 Huard et al., 1999) . These distinctions are likely accounted for by tissue specific expression requirements and by unique properties of each protein (Ciemerych et al., 2002; Carthon et al., 2005) , some of which may be independent of cdk activity regulation (Landis et al., 2006) .
Mice lacking cD1 are runted and die prematurely due to starvation (Sicinski et al., 1995) . In addition to other physical defects, these mice are neurologically impaired, though no distinct neuroanatomical abnormality has been identified (Sicinski et al., 1995; Chen et al., 2005) . In the forebrain, the expression of cD1 is restricted to the embryonic ventricular zone, but curiously, in adult mice, is present in post-mitotic neurons (Tamaru et al., 1994; Glickstein et al., 2007) . Several studies have detailed de-novo expression of cell-cycle proteins in apoptotic, post-mitotic neurons in various neurodegenerative mouse models and in pathological samples from patients having neurodegenerative conditions including Alzheimer's disease, amyotrophic lateral sclerosis, ataxia telangiectasia, Parkinson's disease and stroke (Freeman et al., 1994; Jordan-Sciutto et al., 2003; Ranganathan and Bowser, 2003; Yang and Herrup, 2005; Burns et al., 2007; Herrup and Yang, 2007) . Re-activation of the cell cycle in terminally differentiated neurons is hypothesized to lead to death rather than cell-cycle progression -a theory drawing support from neuroprotection afforded by cell-cycle blocking in models of neuronal apoptosis (Kranenburg et al., 1996; Park et al., 1996 Park et al., , 1997 Padmanabhan et al., 1999) . Several papers have examined cell cycle re-activation in apoptosis, but the unequivocal observation of cD1 in healthy postmitotic neurons that are not destined for imminent apoptosis has not been addressed (Park et al., 2000; Di Giovanni et al., 2005) . Despite the plethora of research articles on the pathogenic consequences of neuronal cD1 expression, we have no understanding of the function served by cD1 in healthy neurons, nor the neuronal cell types and brain regions demonstrating robust, invariable expression. 
